Repeated Intravitreal Bevacizumab Injections versus Single Combined Intravitreal Bevacizumab and Posterior Subtenon Triamcinolone Injections for Treatment of Diabetic Macular Edema
Amin F. Ellakwa, Sameh S. Mandour, Nermeen M. Badawi
Ophthalmology Research: An International Journal · pp. 129–135 · Published 29 Jan 2015
10.9734/OR/2015/15827Abstract
Aim: To compare efficacy of combined intravitreal bevacizumab and subtenon triamcinolone versus three intravitreal injections of bevacizumab at one month interval for reducing foveal thickness. Methods: Sixty eyes of 30 diabetic patients with bilateral diabetic macular edema were randomly enrolled in two groups, group A eyes treated with three intravitreal injections of Bevacizumab of 1 month apart, and group B eyes treated with a single intravitreal injection of Bevacizumab combined with a subtenon triamcinolone in the same operative session. Pre and postoperative clinical data were measured and followed up over 6 months. Results: Difference between pre-treatment and post-treatment clinical data for each parameter in the same group was highly statistically significant. However, on comparing results of post treatment BCVA, IOP and CMT in both groups, there was no statistically significant difference. Conclusion: Combination of subtenon triamcinolone and intravitreal bevacizumab is a safe and effective choice to treat DME.
Cited by 0
No indexed citations yet.
Related research
- The Controversies Surrounding Bevacizumab and Ranibizumab — shares topic coverage
- Relationship of Hemoglobin A1C and Outcomes of Treatment of Diabetic Macular Edema — shares topic coverage
- Recurrent Radiation Retinopathy and Optic Neuropathy after Cranial Irradiation Therapy Treated by Intravitreal Bevacizumab — shares topic coverage
- Therapeutic Efficacy of Intravitreal Bevacizumab (Avastin)® in Patients with Parafoveal Telangiectasia Type II Complicated by Choroidal Neovascular Membrane and/or Cystoid Macular Edema — shares topic coverage
- Comparison of Visual Outcomes between Panretinal Photocoagulation and Panretinal Photocoagulation Plus Intravitreal Bevacizumab in Proliferative Diabetic Retinopathy Patients Treated at Northen Zonal Hospital — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.